Empowering the Patient Voice: Genomic Testing and Cancer Care Decisions

Video Library —January 7, 2022
Frank dela Rama, RN, MS, AOCNS
Clinical Nurse Specialist
Sutter Palo Alto Foundation
Sara Campbell, BS, BSN, OCN
Associate Director
Medical Science Liaisons
Exact Sciences
Jim G.
Oncotype DX® Genomic Prostate Score Patient

In this roundtable discussion presented by AONN+ and supported by Exact Sciences, a panel of experts discuss the critical role of nurse navigators in educating cancer patients about genomic testing and how to interpret the results. Topics include:

  • Genomic versus genetic testing – What’s the difference?
  • Benefits of genomic testing across different cancer types
  • The role of nurse navigators in educating cancer patients about genomic testing

Presented by AONN+

Supported by  Exact Sciences

Related Articles
Keynote: Genetic Therapies Will Explode, Better Access to Data Will Drive Value
June 2022 Vol 13, No 6
Over the past 5 years, there have been 20 FDA approvals of novel genetic medicine technologies – and this is just the beginning. Here’s a glimpse of what’s coming ahead.
AONN+ 2020 CEU Monograph: Early Detection, Vaping, Fertility Preservation, and Genetic Testing
Meg Barbor, MPH
December 2020 Vol 11, No 12
Proceedings from key sessions from an AONN+ conference are presented in this CEU activity.
Direct-to-Consumer Genetic Testing: What Patients and Providers Should Know
September 2020 Vol 11, No 9
Navigators can meet the ever-growing needs of patients undergoing genetic testing. Here’s how.
Last modified: August 10, 2023

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
    Profession or Role
    Primary Specialty or Disease State